Literature DB >> 27262046

NICE guidance: why not clozapine for treatment-refractory bipolar disorder?

Tarun Bastiampillai1, Arun Gupta2, Stephen Allison3, Sherry Kit Wa Chan4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27262046     DOI： 10.1016/S2215-0366(16)30081-5

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN： 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  1 in total

1.  Effectiveness of clozapine, oxcarbazepine and rivastigmine combination in a bipolar disorder patient with initial cerebral atrophy.

Authors:  Paolo Morana; Federico Mucci; Stefano Baroni; Alessandra Della Vecchia; Armando Piccinni; Benedetto Morana; Donatella Marazziti
Journal:  Clin Case Rep       Date:  2020-01-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.